{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:07:49Z","timestamp":1792012069970,"version":"4.4.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.dld.2008.02.028","type":"journal-article","created":{"date-parts":[[2008,4,25]],"date-time":"2008-04-25T17:03:32Z","timestamp":1209143012000},"page":"523-530","source":"Crossref","is-referenced-by-count":81,"title":["Non-invasive tests in gastric diseases"],"prefix":"10.1016","volume":"40","author":[{"given":"F.","family":"di Mario","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.G.","family":"Cavallaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2008.02.028_bib1","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1055\/s-2004-814178","article-title":"Diagnosis of esophagogastric tumors","volume":"36","author":"Lambert","year":"2004","journal-title":"Endoscopy"},{"key":"10.1016\/j.dld.2008.02.028_bib2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0960-7404(00)00016-5","article-title":"The use of molecular biology in diagnosis and prognosis of gastric cancer","volume":"9","author":"Becker","year":"2000","journal-title":"Surg Oncol"},{"key":"10.1016\/j.dld.2008.02.028_bib3","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/jso.20214","article-title":"Gastric cancer: new genetic development","volume":"90","author":"Linch","year":"2005","journal-title":"Surg Oncol"},{"key":"10.1016\/j.dld.2008.02.028_bib4","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1097\/00004836-200305001-00008","article-title":"The gastritis connection. Prevention and early detection of gastric neoplasms","volume":"36","author":"Genta","year":"2003","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.dld.2008.02.028_bib5","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00004836-200006000-00001","article-title":"A new paradigm for human carcinogenesis","volume":"30","author":"Correa","year":"2000","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.dld.2008.02.028_bib6","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0016-5085(82)90176-7","article-title":"Relationship among serum pepsinogen I, serum pepsinogen II and serum gastric mucosa histology","volume":"83","author":"Samloff","year":"1982","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2008.02.028_bib7","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/S0016-5085(19)32321-2","article-title":"A study of the relationship between serum group I pepsinogen and gastric acid secretion","volume":"69","author":"Samloff","year":"1975","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2008.02.028_bib8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0016-5085(19)32639-3","article-title":"Serum group I pepsinogens by radioimmunoassay in control subjects and patients with peptic ulcer","volume":"69","author":"Samloff","year":"1975","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2008.02.028_bib9","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1056\/NEJM197901113000203","article-title":"Duodenal ulcer disease associated with elevated serum pepsinogen I: an inherited autosomal disorder","volume":"300","author":"Rotter","year":"1979","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2008.02.028_bib10","first-page":"831","article-title":"Recurrence of duodenal ulcer under continuous antisecretory treatment: an approach to the detection of predictive markers","volume":"79","author":"Battaglia","year":"1984","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2008.02.028_bib11","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/S0140-6736(88)90929-4","article-title":"Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori","volume":"2","author":"Marshall","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2008.02.028_bib12","first-page":"2111","article-title":"Long term sequelae of Helicobacter pylori gastritis","volume":"55","author":"Kuipers","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2008.02.028_bib13","first-page":"943","article-title":"\u201cFamilial hyperpesinogenemia\u201d and Helicobacter pylori infection","volume":"95","author":"Mertz","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2008.02.028_bib14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0016-5085(19)33138-5","article-title":"Cellular localization of the group II in human stomach and duodenum by immunofluorescence","volume":"65","author":"Samloff","year":"1973","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2008.02.028_bib15","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2169\/internalmedicine.46.6181","article-title":"Serum pepsinogen and gastric cancer screening","volume":"46","author":"Mukoubayashi","year":"2007","journal-title":"Intern Med"},{"key":"10.1016\/j.dld.2008.02.028_bib16","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/0016-5085(92)90156-S","article-title":"Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population","volume":"102","author":"Asaka","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2008.02.028_bib17","first-page":"1211","article-title":"Helicobacter pylori infection and serum pepsinogen A, pepsinogen C, and gastrin in gastritis and peptic ulcer: significance of inflammation and effect of bacterial eradication","volume":"89","author":"Wagner","year":"1994","journal-title":"Am J Gasteroenterol"},{"key":"10.1016\/j.dld.2008.02.028_bib18","first-page":"954","article-title":"Helicobacter pylori serology in patients with chronic gastritis","volume":"91","author":"Plebani","year":"1996","journal-title":"Am J Gasteroenterol"},{"key":"10.1016\/j.dld.2008.02.028_bib19","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1046\/j.1523-5378.2001.00031.x","article-title":"Variation in serum pepsinogens with severity and topography of Helicobacter pylori-associated chronic gastritis in dyspeptic patients referred for endoscopy","volume":"6","author":"Bodger","year":"2001","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2008.02.028_bib20","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1007\/s10620-006-9206-1","article-title":"Usefulness of serum pepsinogens in Helicobacter pylori chronic gastritis: relationship with inflammation, activity, and density of the bacterium","volume":"51","author":"Di Mario","year":"2006","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2008.02.028_bib21","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000081517","article-title":"Clinical usefulness of serum pepsinogens II in the management of Helicobacter pylori infection","volume":"70","author":"Di Mario","year":"2004","journal-title":"Digestion"},{"key":"10.1016\/j.dld.2008.02.028_bib22","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/00042737-200308000-00009","article-title":"Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study","volume":"15","author":"Vaananen","year":"2003","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2008.02.028_bib23","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0009-9120(83)94279-0","article-title":"Pepsinogen group I radioimmunoassay and total serum pepsinogen colorimetric determination: a comparative study in normal subjects and in peptic ulcer patients","volume":"16","author":"Plebani","year":"1983","journal-title":"Clin Biochem"},{"key":"10.1016\/j.dld.2008.02.028_bib24","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1136\/jcp.2005.036111","article-title":"Gastric histology, serological markers and age as predictors of gastric acid secretion in patients infected with Helicobacter pylori","volume":"59","author":"Derakhshan","year":"2006","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.dld.2008.02.028_bib25","first-page":"1249","article-title":"Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and serum pepsinogen I\/II ratio\u2014a possible novel non-invasive marker for gastric atrophy","volume":"51","author":"Suzuki","year":"2004","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.dld.2008.02.028_bib26","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1080\/713786525","article-title":"Serum levels of amigdated gastrin-17 and pepsinogen I in atrophic gastritis: an observational case\u2013control study","volume":"37","author":"Sipponen","year":"2002","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2008.02.028_bib27","first-page":"1691","article-title":"The cost-effectiveness of diagnostic testing strategies for Helicobacter pylori","volume":"95","author":"Vakil","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2008.02.028_bib28","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.dld.2005.01.016","article-title":"Clinical usefulness of serum pepsinogens I and II, gastrin-17 and anti-Helicobacter pylori antibodies in the management of dyspeptic patients in primary care","volume":"37","author":"German\u00e0","year":"2005","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2008.02.028_bib29","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1128\/JCM.36.6.1808-1810.1998","article-title":"Positive result by serology indicates active Helicobacter pylori infection in patients with atrophic gastritis","volume":"36","author":"Kokkola","year":"1998","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.dld.2008.02.028_bib30","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/gut.2006.106666","article-title":"Gastritis staging in clinical practice: the olga staging system","volume":"56","author":"Rugge","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.dld.2008.02.028_bib31","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1158\/1055-9965.EPI-05-0901","article-title":"Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case\u2013control study","volume":"15","author":"Sasazuki","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.dld.2008.02.028_bib32","first-page":"2111","article-title":"Helicobacter pylori and atrophic gastritis: importance of the CagA status","volume":"55","author":"Kuipers","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.dld.2008.02.028_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-0215(19960703)67:1<1::AID-IJC1>3.0.CO;2-0","article-title":"IgG immuno response to Helicobacter pylori antigens in patients with gastric cancer as defined by ELISA and immunoblotting","volume":"67","author":"Klaamas","year":"1996","journal-title":"Int J Cancer"},{"key":"10.1016\/j.dld.2008.02.028_bib34","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/35006081","article-title":"Interleukin-1 polymorphism associated with increased risk of gastric cancer","volume":"404","author":"El Omar","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.dld.2008.02.028_bib35","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1046\/j.1365-2362.2003.01101.x","article-title":"Ratio between serum IL-8 and pepsinogen A\/C: a marker for atrophic body gastritis","volume":"33","author":"Sanduleanu","year":"2003","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.dld.2008.02.028_bib36","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1172\/JCI113344","article-title":"The major parietal cell antigen in autoimmune gastritis with pernicious anemia is the acid-producing H+, K+ adenosine triphosphatase of the stomach","volume":"81","author":"Karlsson","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1016\/j.dld.2008.02.028_bib37","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/08916938809010680","article-title":"Complement fixing gastric parietal-cell autoantibodies. A good marker for the identification of type A chronic atrophic gastritis","volume":"1","author":"Betterle","year":"1988","journal-title":"Autoimmunity"},{"key":"10.1016\/j.dld.2008.02.028_bib38","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1053\/gast.1996.v111.pm8780570","article-title":"Antigenic mimicry between Helicobacter pylori and gastric mucosa in the pathogenesis of body atrophic gastritis","volume":"111","author":"Negrini","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2008.02.028_bib39","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1523-5378.2003.00187.x","article-title":"Helicobacter pylori and gastric autoimmune diseases: is there a link?","volume":"8","author":"Presotto","year":"2003","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2008.02.028_bib40","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/003655202317284183","article-title":"Role of anti-parietal cell antibody in Helicobacter pylori-associated atrophic gastritis: evaluation in a country of high prevalence of atrophic gastritis","volume":"37","author":"Ito","year":"2002","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2008.02.028_bib41","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000088396","article-title":"Biomarkers in patients with gastric inflammation: a systematic review","volume":"72","author":"Naito","year":"2005","journal-title":"Digestion"},{"key":"10.1016\/j.dld.2008.02.028_bib42","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1080\/003655200750023011","article-title":"Implications of serum pepsinogen I in early endoscopic diagnosis of gastric cancer and dysplasia. Helsinki Gastritis Study Group","volume":"35","author":"Varis","year":"2000","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2008.02.028_bib43","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1136\/gut.2004.055400","article-title":"Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study","volume":"54","author":"Watabe","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.dld.2008.02.028_bib44","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/aje\/kwj088","article-title":"The serum pepsinogen test as a predictor of gastric cancer: the Hisayama study","volume":"163","author":"Oishi","year":"2006","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.dld.2008.02.028_bib45","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1572-0241.2003.07410.x","article-title":"Usefulness of gastric cancer screening using the serum pepsinogen test method","volume":"98","author":"Miki","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2008.02.028_bib46","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1440-1746.2005.03983.x","article-title":"Severity of atrophic gastritis related to antiparietal cells and gastric carcinogenesis, including p53 mutations","volume":"21","author":"Taguchi","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2008.02.028_bib47","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/ijc.22435","article-title":"CagA+ Helicobacter pylori infection and gastric cancer risk in the EPIC-EURGAST study","volume":"120","author":"Palli","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.dld.2008.02.028_bib48","first-page":"107","article-title":"Screening markers for chronic atrophic gastritis in Chiapas, Mexico","volume":"10","author":"Ley","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.dld.2008.02.028_bib49","doi-asserted-by":"crossref","first-page":"7172","DOI":"10.3748\/wjg.v12.i44.7172","article-title":"Non-invasive diagnosis of gastric mucosal atrophy in an asymptomatic population with high prevalence of gastric cancer","volume":"28","author":"Rollan","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2008.02.028_bib50","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s10238-006-0098-3","article-title":"Association of serum pepsinogen with atrophic body gastritis in Costa Rica","volume":"6","author":"Sierra","year":"2006","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.dld.2008.02.028_bib51","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/sj.bjc.6600877","article-title":"Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics","volume":"88","author":"Broutet","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.dld.2008.02.028_bib52","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1111\/j.1572-0241.2004.40614.x","article-title":"Serological markers for gastric atrophy in asymptomatic patients with Helicobacter pylori","volume":"99","author":"Ricci","year":"2004","journal-title":"Am J Gastreoenterol"},{"key":"10.1016\/j.dld.2008.02.028_bib53","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/j.1365-2036.2005.02734.x","article-title":"Diagnostic accuracy of the serum profile of gastric mucosa in relation to histological and morphometric diagnosis of atrophy","volume":"22","author":"Nardone","year":"2005","journal-title":"Aliment Ther Pharmacol"},{"key":"10.1016\/j.dld.2008.02.028_bib54","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.cgh.2005.11.003","article-title":"Noninvasive versus histologic detection of gastric atrophy in a Hispanic population in North America","volume":"4","author":"Graham","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2008.02.028_bib55","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1258\/0969141041732184","article-title":"Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening","volume":"11","author":"Dinis-Ribeiro","year":"2004","journal-title":"J Med Screen"},{"key":"10.1016\/j.dld.2008.02.028_bib56","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s10120-006-0397-0","article-title":"Gastric cancer screening using the serum pepsinogen test method","volume":"9","author":"Miki","year":"2006","journal-title":"Gastric Cancer"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S159086580800087X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S159086580800087X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T19:58:16Z","timestamp":1588622296000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S159086580800087X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":56,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S159086580800087X"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2008.02.028","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}